LENZ Therapeutics LENZ
NASDAQ LENZ
$3.66 -0.13 (-3.30%)
As of: Oct 2, 2026 · 11:58 AM EDT

LENZ Therapeutics (LENZ) Depreciation & Amortization (CF) (2020 - 2026)

Updated

LENZ Therapeutics' Depreciation & Amortization (CF) was $110,000 in Q2 2026, up 478.9% from $19,000 a year earlier but down 0.9% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, LENZ Therapeutics' Depreciation & Amortization (CF) was $453,000 through Jun 30, 2026, up 403.3% year-over-year; for FY2025, it was $287,000, up 394.8% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $58,000 in FY2024 (+286.7%), $15,000 in FY2023 (-99.4%), $2.35 million in FY2022 (+220.4%) and $734,000 in FY2021 (+506.6%).
  • Quarterly Depreciation & Amortization (CF) has moved between $3,000 (Q1 2023) and $682,000 (Q4 2022) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for three straight quarters, with growth averaging 330.8% over the last seven quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2025 (growth of 620.0%); the worst was Q4 2023 (a decline of 99.4%).
  • Per Business Quant data, LENZ's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $111,000 (Q1 2026), $107,000 (Q4 2025) and $125,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 LENZ Therapeutics 120.64 Mn 120.64 Mn 5.21 Mn 110,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 110,000.00
Mar 31, 2026 111,000.00
Dec 31, 2025 107,000.00
Sep 30, 2025 125,000.00
Jun 30, 2025 19,000.00
Mar 31, 2025 36,000.00
Dec 31, 2024 25,000.00
Sep 30, 2024 10,000.00
Jun 30, 2024 18,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 4,000.00
Sep 30, 2023 4,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 3,000.00
Dec 31, 2022 682,000.00
Sep 30, 2022 652,000.00
Jun 30, 2022 578,000.00
Mar 31, 2022 440,000.00
Dec 31, 2021 330,000.00
Sep 30, 2021 198,000.00
API Access

LENZ Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LENZ&period=max&api_key=YOUR_API_KEY